Heart Test Laboratories, Inc. (HSCS)

5.83 +0.06 (+1.04%) As of 02:35PM EDT. Market open.

Heart Test Laboratories, Inc.

550 Reserve Street
Suite 360
Southlake, TX 76092
United States
682 237 7781
https://heartsciences.com

Sector(s): Healthcare
Industry: Medical Devices
Full-time employees: 12

Key executives

Name	Title	Pay	Exercised	Year born
Mr. Andrew Simpson	CEO, President & Chairman of the Board of Directors	264.14k	N/A	1970
Ms. Danielle Watson	CFO & Treasurer	188.75k	N/A	1983
Mr. Mark T. Hilz	COO, Secretary & Director	263.61k	N/A	1959

Amounts are as of 31 December 2023, and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

Heart Test Laboratories, Inc., doing business as HeartSciences, is a medical technology company focuses on applying AI-based technology to an ECG to expand and improve an ECG's clinical utility. It is developing AI-ECG solutions to be made available on a hardware agnostic cloud-based platform or its proprietary MyoVista wavECG device, to help identify cardiovascular disease in any care setting worldwide in a manner to suit different care providers. Its first product candidate for FDA clearance, the MyoVista wavECG, or the MyoVista, is a resting 12-lead ECG that is designed to provide diagnostic information related to cardiac dysfunction. The MyoVista also provides conventional ECG information in the same test. The company was incorporated in 2007 and is headquartered in Southlake, Texas.

Corporate governance

Heart Test Laboratories, Inc.’s ISS governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.